Olema Pharmaceuticals, Inc. (OLMA)
29.86
+3.28
(+12.34%)
USD |
NASDAQ |
Dec 10, 13:19
Olema Pharmaceuticals EPS Diluted (Quarterly): -0.4924 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| Replimune Group, Inc. | -0.9041 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Insmed, Inc. | -1.747 |
| Altimmune, Inc. | -0.2126 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -42.22M |
| Total Expenses (Quarterly) | 42.22M |
| Enterprise Value | 1.500B |
| Earnings Yield | -6.07% |
| Normalized Earnings Yield | -6.068 |